πŸ”₯πŸ” BizChicken πŸ”πŸ”₯

Companies Similar to Fractyl Health, Inc. Common Stock

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

BioRestorative Therapies, Inc.

BioRestorative Therapies, Inc. logo
Market Cap: Lowest
Employees: Lowest

BRTX-100

Bio Restorative Therapies, Inc., a life sciences company, focuses on developing regenerative medicine products and therapies primarily involving adult stem cells to treat disc/spine disease and metabolic disorders.

Tags: biotechnology, cell therapy, disc/spine disease, metabolic disorders, regenerative medicine, stem cells

Symbol: BRTX

Recent Price: $1.44

Industry: Biotechnology

CEO: Mr. Lance Alstodt

Sector: Healthcare

Employees: 11

Address: 40 Marcus Drive, Melville, NY 11747

Phone: 631 760 8100

Last updated: 2024-12-31

Fulcrum Therapeutics, Inc.

Fulcrum Therapeutics, Inc. logo
Market Cap: Low
Employees: Low

losmapimod and FTX-6058

Fulcrum Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing products to improve the lives of patients with genetically defined diseases in areas of high unmet medical need in the United States.

Tags: FTX-6058, biopharmaceutical, clinical-stage, facioscapulohumeral muscular dystrophy, genetically defined diseases, hemoglobinopathies, losmapimod, sickle cell disease

Symbol: FULC

Recent Price: $4.68

Industry: Biotechnology

CEO: Mr. Alexander C. Sapir

Sector: Healthcare

Employees: 76

Address: 26 Landsdowne Street, Cambridge, MA 02139

Phone: 617 651 8851

Last updated: 2024-12-31

Revelation Biosciences, Inc.

Revelation Biosciences, Inc. logo
Market Cap: Lowest
Employees: Lowest

REVTx-99b

Revelation Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing immune system therapeutics and diagnostics, including products for chronic nasal congestion, allergic rhinitis, chronic organ disease, and viral infections.

Tags: allergic rhinitis, biopharmaceutical, clinical trial, diagnostics, immune system therapeutics, kidney disease, nasal congestion, viral infections

Symbol: REVB

Recent Price: $0.39

Industry: Biotechnology

CEO: Mr. James M. Rolke

Sector: Healthcare

Employees: 9

Address: 4660 La Jolla Village Drive, San Diego, CA 92122

Phone: 650-800-3717

Last updated: 2024-12-31

Reviva Pharmaceuticals Holdings, Inc.

Reviva Pharmaceuticals Holdings, Inc. logo
Market Cap: Lowest
Employees: Lowest

RP5063

Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing next-generation therapeutics for unmet medical needs, particularly in central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases.

Tags: CNS diseases, RP1208, RP5063, biopharmaceutical, clinical-stage, therapeutics

Symbol: RVPH

Recent Price: $1.81

Industry: Biotechnology

CEO: Dr. Laxminarayan Bhat Ph.D.

Sector: Healthcare

Employees: 15

Address: 19925 Stevens Creek Boulevard, Cupertino, CA 95014

Phone: 408 501 8881

Last updated: 2024-12-31

Revvity, Inc.

Revvity, Inc. logo
Market Cap: Highest
Employees: Highest

Solutions for Diagnostics and Life Sciences

Revvity, Inc. offers a range of products, services, and solutions across diagnostics, life sciences, and applied services markets globally, with a focus on Discovery & Analytical Solutions and Diagnostics.

Tags: Analytical Solutions, Diagnostics, Imaging Technologies, Informatics, Instruments, Life Sciences, Reagents

Symbol: RVTY

Recent Price: $111.31

Industry: Medical - Diagnostics & Research

CEO: Dr. Prahlad R. Singh Ph.D.

Sector: Healthcare

Employees: 11000

Address: 940 Winter Street, Waltham, MA 02451

Phone: 781 663 6900

Last updated: 2024-12-31

Black Diamond Therapeutics, Inc.

Black Diamond Therapeutics, Inc. logo
Market Cap: Low
Employees: Lowest

BDTX-189, BDTX-1535, BDTX-4933

Black Diamond Therapeutics, Inc. is a biotechnology company that discovers, develops, and commercializes medicines for patients with genetically defined tumors. The company focuses on creating irreversible small molecule inhibitors to target specific oncogenic proteins.

Tags: biotechnology, cancer treatment, genetically defined tumors, small molecule inhibitors

Symbol: BDTX

Recent Price: $2.15

Industry: Biotechnology

CEO: Dr. Mark A. Velleca M.D., Ph.D.

Sector: Healthcare

Employees: 54

Address: One Main Street, Cambridge, MA 02142

Phone: 617 252 0848

Leadership

  • Ali Behbahani, M.D., Co-Head of Healthcare, NEA
  • Shannon Campbell, Executive Vice President and Chief Commercial Officer, Merus
  • Kapil Dhingra, M.D., Former Head, Roche Oncology Development
  • Samarth (Sam) Kulkarni, Ph.D., CEO, CRISPR Therapeutics AG
  • Garry E. Menzel, Ph.D., Operating Partner, GHO Capital Partners LLP
  • Prakash Raman, Ph.D., CEO of InduPro, Inc.
  • Mark A. Velleca, M.D., Ph.D., CEO and Board Chair

Last updated: 2024-12-31

Biomerica, Inc.

Biomerica, Inc. logo
Market Cap: Lowest
Employees: Low

diagnostic and therapeutic products

Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures, and markets diagnostic and therapeutic products for medical conditions and diseases worldwide, focusing on gastrointestinal diseases, food intolerances, and diabetes.

Tags: biomedical, diabetes, diagnostic, food intolerances, gastrointestinal, therapeutic

Symbol: BMRA

Recent Price: $0.31

Industry: Medical - Devices

CEO: Mr. Zackary S. Irani

Sector: Healthcare

Employees: 64

Address: 17571 Von Karman Avenue, Irvine, CA 92614

Phone: 949 645 2111

Last updated: 2024-12-31

DarioHealth Corp.

DarioHealth Corp. logo
Market Cap: Lowest
Employees: Low

Dario's metabolic solutions

Dario Health Corp. is a digital therapeutics company offering solutions for metabolic health, MSK conditions, behavioral health, and chronic condition management.

Tags: MSK conditions, behavioral health, diabetes, digital therapeutics, healthcare technology, hypertension, metabolic health, weight management

Symbol: DRIO

Recent Price: $0.79

Industry: Medical - Diagnostics & Research

CEO: Mr. Erez Raphael

Sector: Healthcare

Employees: 223

Address: 18 West 18th Street, New York, NY 10011

Phone: 833 914 3796

Last updated: 2024-12-31

Dermata Therapeutics, Inc.

Dermata Therapeutics, Inc. logo
Market Cap: Lowest
Employees: Lowest

DMT310

Dermata Therapeutics, Inc. is a clinical-stage biotechnology company specializing in the development and commercialization of pharmaceutical candidates for treating medical and aesthetic skin conditions. The company focuses on products such as DMT310 for acne, rosacea, and psoriasis, and DMT410 for hyperhidrosis and aesthetic conditions.

Tags: acne, biotechnology, clinical trials, hyperhidrosis, pharmaceuticals, psoriasis, rosacea, skin conditions

Symbol: DRMA

Recent Price: $1.34

Industry: Biotechnology

CEO: Mr. Gerald T. Proehl

Sector: Healthcare

Employees: 8

Address: 3525 Del Mar Heights Road, San Diego, CA 92130

Phone: 858 800 2543

Last updated: 2024-12-31

4D Molecular Therapeutics, Inc.

4D Molecular Therapeutics, Inc. logo
Market Cap: Medium
Employees: Low

4D-125, 4D-110, 4D-310, 4D-150, 4D-710

4D Molecular Therapeutics, Inc. is a clinical-stage gene therapy company developing product candidates using adeno-associated virus vectors, focusing on ophthalmology, cardiology, and pulmonology.

Tags: biotechnology, cardiology, gene therapy, ophthalmology, pulmonology

Symbol: FDMT

Recent Price: $5.30

Industry: Biotechnology

CEO: Dr. David H. Kirn M.D.

Sector: Healthcare

Employees: 201

Address: 5858 Horton Street, EmeryVille, CA 94608

Phone: 510 505 2680

Last updated: 2024-12-31

FibroGen, Inc.

FibroGen, Inc. logo
Market Cap: Lowest
Employees: Medium

Roxadustat, Pamrevlumab

Fibro Gen, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing therapeutics to treat serious unmet medical needs, including treatments for anemia, idiopathic pulmonary fibrosis, and Duchenne muscular dystrophy.

Tags: anemia, antibody, biopharmaceutical, cancer, kidney disease, pulmonary fibrosis, therapeutics

Symbol: FGEN

Recent Price: $0.53

Industry: Biotechnology

CEO: Mr. Thane Wettig

Sector: Healthcare

Employees: 486

Address: 409 Illinois Street, San Francisco, CA 94158

Phone: 415 978 1200

Last updated: 2024-12-31

Fractyl Health, Inc. Common Stock

Fractyl Health, Inc. Common Stock logo
Market Cap: Low
Employees: Low

Revita DMR System

Fractyl Health, Inc. develops therapies for type 2 diabetes and obesity, including the Revita DMR System and Rejuva gene therapy platform.

Tags: gene therapy, healthcare, metabolic therapeutics, obesity, type 2 diabetes

Symbol: GUTS

Recent Price: $2.03

Industry: Biotechnology

CEO: Dr. Harith Rajagopalan M.D., Ph.D.

Sector: Healthcare

Employees: 112

Address: 17 Hartwell Avenue, Lexington, null 02421

Phone: 781-902-8800

Last updated: 2024-12-31

Revolution Medicines, Inc.

Revolution Medicines, Inc. logo
Market Cap: Highest
Employees: Medium

RMC-4630

Revolution Medicines, Inc. is a clinical-stage precision oncology company focused on developing therapies targeting frontier targets in RAS-addicted cancers.

Tags: RAS-addicted cancers, cancer therapy, clinical trials, oncology, precision medicine

Symbol: RVMD

Recent Price: $43.17

Industry: Biotechnology

CEO: Dr. Mark A. Goldsmith Ph.D.

Sector: Healthcare

Employees: 378

Address: 700 Saginaw Drive, Redwood City, CA 94063

Phone: 650 481 6801

Last updated: 2024-12-31

Revance Therapeutics, Inc.

Revance Therapeutics, Inc. logo
Market Cap: Medium
Employees: Medium

Daxibotulinumtoxin A

Revance Therapeutics, Inc. is a biotechnology company focused on developing, manufacturing, and commercializing neuromodulators for various aesthetic and therapeutic indications.

Tags: aesthetic, biotechnology, clinical trials, neuromodulators, therapeutic

Symbol: RVNC

Recent Price: $3.06

Industry: Biotechnology

CEO: Mr. Mark J. Foley

Sector: Healthcare

Employees: 597

Address: 1222 Demonbreun Street, Nashville, TN 37203

Phone: 615 724 7755

Leadership

  • Mark J. Foley, Chief Executive Officer
  • Tobin Schilke, Chief Financial Officer
  • Erica Jordan, Chief Commercial Officer
  • Dwight O. Moxie, Chief Legal Officer and General Counsel
  • Amie Krause, Chief People Officer
  • David A. Hollander, Chief Medical Officer, Global Therapeutics Franchise Lead
  • Angus C. Russell, CHAIRMAN OF THE BOARD, CHAIR, NOMINATING AND GOVERNANCE COMMITTEE
  • Chris Nolet, Chair, Audit Committee
  • Jill Beraud, CHAIR, BRAND COMMITTEE, COMPENSATION COMMITTEE
  • Vlad Coric,
  • Julian S. Gangolli,
  • Carey O’Connor Kolaja,
  • Olivia C. Ware,

Last updated: 2024-12-31

Rhythm Pharmaceuticals, Inc.

Rhythm Pharmaceuticals, Inc. logo
Market Cap: High
Employees: Low

IMCIVREE

Rhythm Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company dedicated to developing and commercializing treatments for rare genetic diseases of obesity. Their lead product, IMCIVREE, targets specific genetic disorders causing obesity, and they are also advancing other therapeutic candidates through clinical trials.

Tags: IMCIVREE, biopharmaceutical, genetic diseases, obesity, therapeutics

Symbol: RYTM

Recent Price: $56.34

Industry: Biotechnology

CEO: Dr. David P. Meeker M.D.

Sector: Healthcare

Employees: 226

Address: 222 Berkeley Street, Boston, MA 02116

Phone: 857 264 4280

Last updated: 2024-12-31

Rezolute, Inc.

Rezolute, Inc. logo
Market Cap: Low
Employees: Lowest

RZ358

Rezolute, Inc. is a clinical stage biopharmaceutical company focused on developing transformative therapies for metabolic diseases related to chronic glucose imbalance. Its lead product, RZ358, is aimed at treating congenital hyperinsulinism.

Tags: biopharmaceutical, clinical stage, congenital hyperinsulinism, genetic disorder, glucose imbalance, metabolic diseases

Symbol: RZLT

Recent Price: $4.89

Industry: Biotechnology

CEO: Mr. Nevan Charles Elam J.D.

Sector: Healthcare

Employees: 59

Address: 201 Redwood Shores Parkway, Redwood City, CA 94065

Phone: 650 206 4507

Last updated: 2024-12-31

Syros Pharmaceuticals, Inc.

Syros Pharmaceuticals, Inc. logo
Market Cap: Lowest
Employees: Low

Tamibarotene

Syros Pharmaceuticals is a biopharmaceutical company focused on developing treatments for cancer and monogenic diseases through gene control medicines. Key products include Tamibarotene for myelodysplastic syndrome and acute myeloid leukemia, and SY-5609 for advanced solid tumors.

Tags: acute myeloid leukemia, biopharmaceutical, cancer treatment, gene control, myelodysplastic syndrome, pharmaceutical development

Symbol: SYRS

Recent Price: $0.25

Industry: Biotechnology

CEO: Mr. Conley Chee

Sector: Healthcare

Employees: 68

Address: 35 CambridgePark Drive, Cambridge, MA 02140

Phone: 617 744 1340

Leadership

  • Conley Chee, President and Chief Executive Officer
  • Jason Haas, Chief Financial Officer
  • Gerald E. Quirk, Chief Legal & Compliance Officer; Chief Business Officer
  • Lisa Roberts, VP Human Resources
  • David A. Roth, M.D., Chief Medical Officer
  • Kristin Stephens, Chief Development Officer

Last updated: 2024-12-31

Viridian Therapeutics, Inc.

Viridian Therapeutics, Inc. logo
Market Cap: High
Employees: Low

VRDN-001, VRDN-002, VRDN-003

Viridian Therapeutics, Inc. is a biotechnology company focused on developing treatments for patients suffering from serious diseases, including thyroid eye disease.

Tags: antibody treatment, biotechnology, clinical trial, therapeutics, thyroid eye disease

Symbol: VRDN

Recent Price: $19.54

Industry: Biotechnology

CEO: Mr. Stephen F. Mahoney J.D., MBA

Sector: Healthcare

Employees: 94

Address: 221 Crescent Street, Waltham, MA 02453

Phone: 617 272 4600

Last updated: 2024-12-31

DiaMedica Therapeutics Inc.

DiaMedica Therapeutics Inc. logo
Market Cap: Low
Employees: Lowest

DM199

Dia Medica Therapeutics Inc. is a clinical stage biopharmaceutical company developing treatments for neurological and kidney diseases, including their lead drug candidate DM199 for chronic kidney disease and acute ischemic stroke.

Tags: acute ischemic stroke, biopharmaceutical, chronic kidney disease, clinical trials, kidney diseases, neurological diseases

Symbol: DMAC

Recent Price: $5.34

Industry: Biotechnology

CEO: Mr. Dietrich John Pauls MBA

Sector: Healthcare

Employees: 18

Address: Two Carlson Parkway, Minneapolis, MN 55447

Phone: 763 612 6755

Leadership

  • Rick Pauls, President & CEO
  • Lorianne Masuoka, Chief Medical Officer
  • Scott Kellen, Chief Financial Officer
  • Ambarish Shah, Ph.D., Chief Technology Officer
  • Dominic Cundari, Chief Commercial Officer
  • David Wambeke, Chief Business Officer
  • Rebekah de Vitry Fries, Vice President of Clinical Operations
  • Dr. Paolo Madeddu, MD, Senior Scientific Advisor and KLK1 Expert

Last updated: 2024-12-31

Madrigal Pharmaceuticals, Inc.

Madrigal Pharmaceuticals, Inc. logo
Market Cap: High
Employees: Medium

resmetirom

Madrigal Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focusing on developing and commercializing therapeutic candidates for cardiovascular, metabolic, and liver diseases, with its lead product candidate resmetirom targeting non-alcoholic steatohepatitis.

Tags: biopharmaceutical, cardiovascular, clinical-stage, liver diseases, metabolic, non-alcoholic steatohepatitis, resmetirom, therapeutic candidates

Symbol: MDGL

Recent Price: $311.62

Industry: Biotechnology

CEO: Mr. William J. Sibold

Sector: Healthcare

Employees: 376

Address: Four Tower Bridge, West Conshohocken, PA 19428

Phone: 267 824 2827

Leadership

  • BILL SIBOLD, Chief Executive Officer
  • REBECCA TAUB, M.D., Director, Founder, Chief Medical Officer and President of Research & Development
  • MARDI C. DIER, Chief Financial Officer
  • CAROLE HUNTSMAN, Chief Commercial Officer
  • CLINT WALLACE, Chief Human Resources Officer
  • RONALD FILIPPO, Chief Information Officer
  • STEPHEN DODGE, PHARM D, M.B.A., Senior Vice President, Global Medical Affairs
  • SHANNON KELLEY, General Counsel
  • MARK BARRETT, Chief Business Officer
  • MARK UNDERWOOD, Senior Vice President, Business Planning & Operations
  • Julian C. Baker, Chairman and Director
  • Kenneth M. Bate, Director
  • Raymond Cheong, M.D., Ph.D., Director
  • Fred Craves, Ph.D., Director
  • James M. Daly, Director
  • Paul A. Friedman, M.D., Director
  • Richard S. Levy, M.D., Director
  • Bill Sibold, Director, Chief Executive Officer
  • Rebecca Taub, M.D., Director, Founder, Chief Medical Officer and President of Research & Development

Last updated: 2024-12-31